BCL2 and neoplasm: The combinational drugs synergistically caused a significant imbalance in Bax/Bcl-2, and led to increased levels of caspase-3, caspase-9 and PARP-1, ultimately resulting in potent tumor suppression in BGC823 cell-xenografted mice 33.